# Life Science REIT PLC 35.7% potential upside indicated by Berenberg Bank

- Link: https://www.directorstalkinterviews.com/life-science-reit-plc-35.7-potential-upside-indicated-by-berenberg-bank/4121176205
- Published: 2024-11-04T14:36:35+00:00
- Author: Charlotte Edwards

**Life Science REIT PLC** with ticker (LON:LABS) now has a potential upside of 35.7%
according to Berenberg Bank.
LABS.LBerenberg Bank set a target price of 57 GBX for
the company, which when compared to the Life Science REIT PLC share price of 42 
GBX at opening today (04/11/2024) indicates a potential upside of 35.7%. Trading
has ranged between 31 (52 week low) and 69 (52 week high) with an average of 1,157,388
shares exchanging hands daily. The market capitalisation at the time of writing 
is £149,099,994.MediPharm Labs Corp. is a Canada-based full-service pharmaceutical
company. The Company specializes in the development and manufacture of purified,
pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (
API) and advanced derivative products. Through its wholesale and white label platforms,
the Company formulates, develops (including through sensory testing), processes,
packages and distributes cannabis extracts and advanced cannabinoid-based products
to domestic and international markets. It also provides GMP flower sourcing, packaging,
and distribution services for select international clients. In addition, it cultivates
cannabis to sell as dried flower, pre-roll and other cannabis products for the adult
use and medical markets. It also sells metered dose inhalers and aerosol sublingual
sprays. Through Harvest Medicine, it provides clinic services to Canadian patients
requiring medical cannabis education and prescriptions.

Share on: